Article Versions Notes

Zinellu A, Sucato F, Piras V, Addis GM, Biondi G, Montesu MA, Mangoni AA, Carru C, Pirina P, Paliogiannis P, et al. Blood Cells Count Derived Inflammation Indexes as Predictors of Early Treatment Response to Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis. Journal of Clinical Medicine. 2023; 12(6):2104. https://doi.org/10.3390/jcm12062104

Zinellu, Angelo, Federica Sucato, Viviana Piras, Gian Mario Addis, Gabriele Biondi, Maria Antonia Montesu, Arduino A. Mangoni, Ciriaco Carru, Pietro Pirina, Panagiotis Paliogiannis, and et al. 2023. "Blood Cells Count Derived Inflammation Indexes as Predictors of Early Treatment Response to Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis" Journal of Clinical Medicine 12, no. 6: 2104. https://doi.org/10.3390/jcm12062104

Zinellu, A., Sucato, F., Piras, V., Addis, G. M., Biondi, G., Montesu, M. A., Mangoni, A. A., Carru, C., Pirina, P., Paliogiannis, P., Fois, A. G., & Satta, R. (2023). Blood Cells Count Derived Inflammation Indexes as Predictors of Early Treatment Response to Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis. Journal of Clinical Medicine, 12(6), 2104. https://doi.org/10.3390/jcm12062104